MakCHS Publications

Found 425 results
Author [ Keyword(Desc)] Title Type Year
Filters: First Letter Of Last Name is A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Adolescent
R. K. Wanyenze, Nawavvu, C., Namale, A. S., Mayanja, B., Bunnell, R., Abang, B., Amanyire, G., Sewankambo, N. K., and Kamya, M. R., Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals., Bulletin of the World Health Organization, vol. 86, no. 4, pp. 302-9, 2008.
R. K. Wanyenze, Nawavvu, C., Namale, A. S., Mayanja, B., Bunnell, R., Abang, B., Amanyire, G., Sewankambo, N. K., and Kamya, M. R., Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals., Bulletin of the World Health Organization, vol. 86, no. 4, pp. 302-9, 2008.
F. Bwanga, Disqué, C., Lorenz, M. G., Allerheiligen, V., Worodria, W., Luyombya, A., Najjingo, I., and Weizenegger, M., Higher blood volumes improve the sensitivity of direct PCR diagnosis of blood stream tuberculosis among HIV-positive patients: an observation study., BMC Infect Dis, vol. 15, p. 48, 2015.
M. A. Arroyo, Sateren, W. B., Serwadda, D., Gray, R. H., Wawer, M. J., Sewankambo, N. K., Kiwanuka, N., Kigozi, G., Wabwire-Mangen, F., Eller, M., Eller, L. A., Birx, D. L., Robb, M. L., and McCutchan, F. E., Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda., Journal of acquired immune deficiency syndromes (1999), vol. 43, no. 4, pp. 440-5, 2006.
M. Bwakura-Dangarembizi, Musiime, V., Szubert, A. J., Prendergast, A. J., Gomo, Z. A., Thomason, M. J., Musarurwa, C., Mugyenyi, P., Nahirya, P., Kekitiinwa, A., Gibb, D. M., Walker, A. S., and Nathoo, K., Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy., Pediatr Infect Dis J, vol. 34, no. 2, pp. e23-31, 2015.
D. Serwadda, Gray, R. H., Sewankambo, N. K., Wabwire-Mangen, F., Chen, M. Z., Quinn, T. C., Lutalo, T., Kiwanuka, N., Kigozi, G., Nalugoda, F., Meehan, M. P., Ashley Morrow, R., and Wawer, M. J., Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda., The Journal of infectious diseases, vol. 188, no. 10, pp. 1492-7, 2003.
G. Kigozi, Gray, R. H., Wawer, M. J., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chen, M. Z., Sewankambo, N. K., Wabwire-Mangen, F., Bacon, M. C., Ridzon, R., Opendi, P., Sempijja, V., Settuba, A., Buwembo, D., Kiggundu, V., Anyokorit, M., Nkale, J., Kighoma, N., and Charvat, B., The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda., PLoS medicine, vol. 5, no. 6, p. e116, 2008.
Adult
M. A. Arroyo, Sateren, W. B., Serwadda, D., Gray, R. H., Wawer, M. J., Sewankambo, N. K., Kiwanuka, N., Kigozi, G., Wabwire-Mangen, F., Eller, M., Eller, L. A., Birx, D. L., Robb, M. L., and McCutchan, F. E., Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda., Journal of acquired immune deficiency syndromes (1999), vol. 43, no. 4, pp. 440-5, 2006.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
H. Yoshimine, Oishi, K., Mubiru, F., Nalwoga, H., Takahashi, H., Amano, H., Ombasi, P., Watanabe, K., Joloba, M., Aisu, T., Ahmed, K., Shimada, M., Mugerwa, R., and Nagatake, T., Community-acquired pneumonia in Ugandan adults: short-term parenteral ampicillin therapy for bacterial pneumonia., The American journal of tropical medicine and hygiene, vol. 64, no. 3-4, pp. 172-7, 2001.
G. Kigozi, Gray, R. H., Wawer, M. J., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chen, M. Z., Sewankambo, N. K., Wabwire-Mangen, F., Bacon, M. C., Ridzon, R., Opendi, P., Sempijja, V., Settuba, A., Buwembo, D., Kiggundu, V., Anyokorit, M., Nkale, J., Kighoma, N., and Charvat, B., The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda., PLoS medicine, vol. 5, no. 6, p. e116, 2008.
N. Kiwanuka, Laeyendecker, O., Robb, M., Kigozi, G., Arroyo, M., McCutchan, F., Eller, L. A., Eller, M., Makumbi, F., Birx, D., Wabwire-Mangen, F., Serwadda, D., Sewankambo, N. K., Quinn, T. C., Wawer, M., and Gray, R., Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection., The Journal of infectious diseases, vol. 197, no. 5, pp. 707-13, 2008.
F. Bwanga, Disqué, C., Lorenz, M. G., Allerheiligen, V., Worodria, W., Luyombya, A., Najjingo, I., and Weizenegger, M., Higher blood volumes improve the sensitivity of direct PCR diagnosis of blood stream tuberculosis among HIV-positive patients: an observation study., BMC Infect Dis, vol. 15, p. 48, 2015.
H. Yoshimine, Oishi, K., Mubiru, F., Nalwoga, H., Takahashi, H., Amano, H., Ombasi, P., Watanabe, K., Joloba, M., Aisu, T., Ahmed, K., Shimada, M., Mugerwa, R., and Nagatake, T., Community-acquired pneumonia in Ugandan adults: short-term parenteral ampicillin therapy for bacterial pneumonia., The American journal of tropical medicine and hygiene, vol. 64, no. 3-4, pp. 172-7, 2001.
R. K. Wanyenze, Nawavvu, C., Namale, A. S., Mayanja, B., Bunnell, R., Abang, B., Amanyire, G., Sewankambo, N. K., and Kamya, M. R., Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals., Bulletin of the World Health Organization, vol. 86, no. 4, pp. 302-9, 2008.
H. Brahmbhatt, Sullivan, D., Kigozi, G., Askin, F., Wabwire-Mangenm, F., Serwadda, D., Sewankambo, N., Wawer, M., and Gray, R., Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality., Journal of acquired immune deficiency syndromes (1999), vol. 47, no. 4, pp. 472-6, 2008.
M. J. Boyle, Jagannathan, P., Bowen, K., McIntyre, T. I., Vance, H. M., Farrington, L. A., Greenhouse, B., Nankya, F., Rek, J., Katureebe, A., Arinaitwe, E., Dorsey, G., Kamya, M. R., and Feeney, M. E., Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations., J Infect Dis, vol. 212, no. 3, pp. 416-25, 2015.
R. K. Wanyenze, Nawavvu, C., Namale, A. S., Mayanja, B., Bunnell, R., Abang, B., Amanyire, G., Sewankambo, N. K., and Kamya, M. R., Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals., Bulletin of the World Health Organization, vol. 86, no. 4, pp. 302-9, 2008.
E. H. Geng, Neilands, T. B., Thièbaut, R., Bwana, M. Bosco, Nash, D., Moore, R. D., Wood, R., Zannou, D. Marcel, Althoff, K. N., Lim, P. Lian, Nachega, J. B., Easterbrook, P. J., Kambugu, A., Little, F., Nakigozi, G., Nakanjako, D., Kiggundu, V., Li, P. Chung Ki, Bangsberg, D. R., Fox, M. P., Prozesky, H. W., Hunt, P. W., Davies, M. - A., Reynolds, S. J., Egger, M., Yiannoutsos, C. T., Vittinghoff, E. V., Deeks, S. G., and Martin, J. N., CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa., Int J Epidemiol, vol. 44, no. 1, pp. 251-63, 2015.
D. Serwadda, Gray, R. H., Sewankambo, N. K., Wabwire-Mangen, F., Chen, M. Z., Quinn, T. C., Lutalo, T., Kiwanuka, N., Kigozi, G., Nalugoda, F., Meehan, M. P., Ashley Morrow, R., and Wawer, M. J., Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda., The Journal of infectious diseases, vol. 188, no. 10, pp. 1492-7, 2003.
C. Acuña-Villaorduña, Ayakaka, I., Dryden-Peterson, S., Nakubulwa, S., Worodria, W., Reilly, N., Hosford, J., Fennelly, K. P., Okwera, A., and Jones-López, E. C., High mortality associated with retreatment of tuberculosis in a clinic in Kampala, Uganda: a retrospective study., Am J Trop Med Hyg, vol. 93, no. 1, pp. 73-5, 2015.
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients., AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
H. Yoshimine, Oishi, K., Mubiru, F., Nalwoga, H., Takahashi, H., Amano, H., Ombasi, P., Watanabe, K., Joloba, M., Aisu, T., Ahmed, K., Shimada, M., Mugerwa, R., and Nagatake, T., Community-acquired pneumonia in Ugandan adults: short-term parenteral ampicillin therapy for bacterial pneumonia., The American journal of tropical medicine and hygiene, vol. 64, no. 3-4, pp. 172-7, 2001.
C. Acuña-Villaorduña, Ayakaka, I., Dryden-Peterson, S., Nakubulwa, S., Worodria, W., Reilly, N., Hosford, J., Fennelly, K. P., Okwera, A., and Jones-López, E. C., High mortality associated with retreatment of tuberculosis in a clinic in Kampala, Uganda: a retrospective study., Am J Trop Med Hyg, vol. 93, no. 1, pp. 73-5, 2015.
Antiretroviral Therapy, Highly Active
J. B. Angel, Hu, Y. - W., Kravcik, S., Tsui, R., Lee, K. H., Barbour, J., Balaskas, E., Branson, B. M., Delwart, E. L., and Grant, R. M., Virological evaluation of the 'Ottawa case' indicates no evidence for HIV-1 superinfection., AIDS (London, England), vol. 18, no. 2, pp. 331-4, 2004.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
M. Bwakura-Dangarembizi, Musiime, V., Szubert, A. J., Prendergast, A. J., Gomo, Z. A., Thomason, M. J., Musarurwa, C., Mugyenyi, P., Nahirya, P., Kekitiinwa, A., Gibb, D. M., Walker, A. S., and Nathoo, K., Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy., Pediatr Infect Dis J, vol. 34, no. 2, pp. e23-31, 2015.
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients., AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.

Pages